# A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)

> **NCT00104364** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** MK0731

## Key facts

- **NCT ID:** NCT00104364
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104364, "A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00104364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*